FBTCX vs. ETIHX

Last updated Jun 25, 2026

FBTCX (Fidelity Advisor Biotechnology Fund Class C) and ETIHX (Eventide Healthcare & Life Sciences Fund) are both Health & Biotech Equities funds. Over the past 10 years, FBTCX returned 11.92%/yr vs 14.38%/yr for ETIHX. Their correlation of 0.89 suggests significant overlap in exposure. FBTCX charges 1.75%/yr vs 1.30%/yr for ETIHX.

Performance

FBTCX vs. ETIHX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Eventide Healthcare & Life Sciences Fund (ETIHX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FBTCX achieves a 12.68% return, which is significantly higher than ETIHX's 3.57% return. Over the past 10 years, FBTCX has underperformed ETIHX with an annualized return of 11.92%, while ETIHX has yielded a comparatively higher 14.38% annualized return.

FBTCX

• 1D: 0.90%
• 1M: 9.07%
• YTD: 12.68%
• 6M: 9.34%
• 1Y: 61.64%
• 3Y*: 18.82%
• 5Y*: 8.39%
• 10Y*: 11.92%

ETIHX

• 1D: 0.45%
• 1M: 5.47%
• YTD: 3.57%
• 6M: 1.54%
• 1Y: 56.58%
• 3Y*: 12.11%
• 5Y*: 4.44%
• 10Y*: 14.38%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FBTCX vs. ETIHX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FBTCX Fidelity Advisor Biotechnology Fund Class C	12.68%	38.48%	-2.00%	9.86%	-8.64%	-3.72%	31.17%	24.82%	-4.55%	24.81%
ETIHX Eventide Healthcare & Life Sciences Fund	3.57%	56.73%	-10.13%	11.01%	-19.62%	-16.87%	37.12%	58.74%	-0.27%	45.83%

Correlation

The correlation between FBTCX and ETIHX is 0.86, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.86
Correlation (3Y) Calculated over the trailing 3-year period	0.86
Correlation (5Y) Calculated over the trailing 5-year period	0.88
Correlation (10Y) Calculated over the trailing 10-year period	0.88
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013	0.89

The correlation between FBTCX and ETIHX has been stable across timeframes, ranging from 0.86 to 0.89 - a consistent structural relationship.

Return for Risk

FBTCX vs. ETIHX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBTCX

FBTCX Risk / Return Rank: 89
FBTCX Sharpe Ratio Rank: 92
FBTCX Sortino Ratio Rank: 85
FBTCX Omega Ratio Rank: 76
FBTCX Calmar Ratio Rank: 98
FBTCX Martin Ratio Rank: 95

ETIHX

ETIHX Risk / Return Rank: 80
ETIHX Sharpe Ratio Rank: 83
ETIHX Sortino Ratio Rank: 74
ETIHX Omega Ratio Rank: 64
ETIHX Calmar Ratio Rank: 93
ETIHX Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FBTCX vs. ETIHX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Eventide Healthcare & Life Sciences Fund (ETIHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FBTCX	ETIHX	Difference
Sharpe ratio: Return per unit of total volatility	2.82	2.47	+0.35
Sortino ratio: Return per unit of downside risk	3.73	3.23	+0.49
Omega ratio: Gain probability vs. loss probability	1.45	1.40	+0.05
Calmar ratio: Return relative to maximum drawdown	7.23	4.83	+2.40
Martin ratio: Return relative to average drawdown	19.82	14.55	+5.27

FBTCX vs. ETIHX - Sharpe Ratio Comparison

The current FBTCX Sharpe Ratio is 2.82, which is comparable to the ETIHX Sharpe Ratio of 2.47. The chart below compares the historical Sharpe Ratios of FBTCX and ETIHX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FBTCX vs. ETIHX - Drawdown Comparison

The maximum FBTCX drawdown since its inception was -64.04%, which is greater than ETIHX's maximum drawdown of -55.11%. Use the drawdown chart below to compare losses from any high point for FBTCX and ETIHX.

Drawdown Indicators

	FBTCX	ETIHX	Difference
Max Drawdown Largest peak-to-trough decline	-64.04%	-55.11%	-8.93%
Max Drawdown (1Y) Largest decline over 1 year	-9.04%	-12.50%	+3.46%
Max Drawdown (3Y) Largest decline over 3 years	-37.26%	-33.23%	-4.03%
Max Drawdown (5Y) Largest decline over 5 years	-37.26%	-49.27%	+12.01%
Max Drawdown (10Y) Largest decline over 10 years	-39.37%	-55.11%	+15.74%
Current Drawdown Current decline from peak	0.00%	-0.26%	+0.26%
Average Drawdown Average peak-to-trough decline	-23.04%	-17.94%	-5.10%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.29%	4.14%	-0.85%

Volatility

FBTCX vs. ETIHX - Volatility Comparison

The current volatility for Fidelity Advisor Biotechnology Fund Class C (FBTCX) is 9.23%, while Eventide Healthcare & Life Sciences Fund (ETIHX) has a volatility of 9.88%. This indicates that FBTCX experiences smaller price fluctuations and is considered to be less risky than ETIHX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FBTCX	ETIHX	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.23%	9.88%	-0.65%
Volatility (6M) Calculated over the trailing 6-month period	18.03%	19.81%	-1.78%
Volatility (1Y) Calculated over the trailing 1-year period	23.20%	24.49%	-1.29%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.84%	27.98%	-4.14%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.51%	28.38%	-3.87%

FBTCX vs. ETIHX - Expense Ratio Comparison

FBTCX has a 1.75% expense ratio, which is higher than ETIHX's 1.30% expense ratio.

Dividends

FBTCX vs. ETIHX - Dividend Comparison

FBTCX's dividend yield for the trailing twelve months is around 1.49%, while ETIHX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ETIHX Eventide Healthcare & Life Sciences Fund	0.00%	0.00%	0.00%	0.00%	0.00%	10.78%	3.49%	2.08%	7.33%	1.28%	0.00%	1.22%
FBTCX Fidelity Advisor Biotechnology Fund Class C	1.49%	1.68%	0.00%	0.00%	0.00%	24.50%	9.78%	7.92%	2.92%	0.00%	0.00%	5.73%

Frequently Asked Questions

Can I hold both FBTCX and ETIHX in my portfolio?

FBTCX and ETIHX have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FBTCX or ETIHX?

ETIHX has higher volatility (9.88%) compared to FBTCX (9.23%). In terms of maximum drawdown, FBTCX dropped -64.04% vs ETIHX's -55.11%.

Which has better risk-adjusted returns?

FBTCX currently has the higher Sharpe Ratio (2.82 vs 2.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.